Conecte-se

Bibliografias temáticas / Hepatitis C virus / Artigos de revistas

Siga este link para ver outros tipos de publicações sobre o tema: Hepatitis C virus.

Artigos de revistas sobre o tema "Hepatitis C virus"

Autor: Grafiati

Publicado: 4 de junho de 2021

Última modificação: 28 de julho de 2024

Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos

Selecione um tipo de fonte:

Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Hepatitis C virus".

Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.

Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.

Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.

1

Jamali, Ghulam Mustafa, Anwar Ali Jamali e Habibullah Shaikh. "HEPATITIS C VIRUS;". Professional Medical Journal 24, n.º 11 (3 de novembro de 2017): 1621–29. http://dx.doi.org/10.29309/tpmj/2017.24.11.646.

Texto completo da fonte

Resumo:

Objectives: The plan of this current research was in the direction for towards theassessment of the existing ELISA (Enzyme Linked Immunosorbant Assay) method throughantibodies testing for identification of hepatitis C virus disease by comparing their outcome withthe Real Time polymerase chain reaction analysis. Setting: Peoples Medical College HospitalNawabshah. Period: December 2015 to December 2016. Methods: In this current research 100blood samples were analyzed due to the presence of anti-HCV antibodies by 3rd-generationenzyme-linked immunosorbent assay testing. All the specimens were 100% positive. Polymerasechain reaction test was performed according to the laboratory directions in anti- hepatitis C virusantibodies positive patients to validate the diagnosis of hepatitis C virus infectivity. Results: Thisresearch shows that, the entire results were positive by Enzyme Linked Immunosorbant Assaytesting. As compared with polymerase chain reaction the of Enzyme Linked ImmunosorbantAssay in this research the screening test for anti hepatitis C virus - antibodies is about 2%false positive. Out of the 100 samples 98 cases are positive by Real Time polymerase chainreaction analysis while only 02 cases report are negative (2%). Conclusion: The proportion ofhepatitis C virus infectivity was 100% by 3rd-generation enzyme-linked immunosorbent assaytesting, 98% by Real Time polymerase chain reaction analysis. As in our research the hepatitisC virus –Ribonucleic acid is present in 98% cases who are the Anti- hepatitis C virus antibodiespositive patients, it can be suggested that Anti-HCV antibodies detection by third generationELISA technique in routine procedure is sufficient to determine HCV infection.

Estilos ABNT, Harvard, Vancouver, APA, etc.

2

AYGEN, Bilgehan, Mustafa Kemal ÇELEN, İftihar KÖKSAL, Selma TOSUN, Oğuz KARABAY, Tansu YAMAZHAN, Orhan YILDIZ, Celal AYAZ e Fehmi TABAK. "The Prevalence and Epidemiological Characteristics of Hepatitis B Virus and Hepatitis C Virus Coinfection in Turkey". Turkiye Klinikleri Journal of Medical Sciences 33, n.º 5 (2013): 1245–49. http://dx.doi.org/10.5336/medsci.2012-32319.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

3

MD, Ian R. Mackay. "The new hepatitis virus: hepatitis C virus". Medical Journal of Australia 153, n.º 5 (setembro de 1990): 247–49. http://dx.doi.org/10.5694/j.1326-5377.1990.tb136892.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

4

Kim, Arthur. "Hepatitis C Virus". Annals of Internal Medicine 165, n.º 5 (6 de setembro de 2016): ITC33. http://dx.doi.org/10.7326/aitc201609060.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

5

Kaplan, David E. "Hepatitis C Virus". Annals of Internal Medicine 173, n.º 5 (1 de setembro de 2020): ITC33—ITC48. http://dx.doi.org/10.7326/aitc202009010.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

6

NAQVI, S. M. ABBAS, Muhammad Shiraz Khan, QURBAN ALI KHASKHELI, Muhammad Saeed Talpur e SHAHID HABIB ANSARI. "HEPATITIS C VIRUS". Professional Medical Journal 13, n.º 04 (16 de dezembro de 2006): 604–7. http://dx.doi.org/10.29309/tpmj/2006.13.04.4935.

Texto completo da fonte

Resumo:

`To find out the prevalence of antibody to HCV in serum of blood donorpopulation in our Community (Karachi). To estimate level of serum ALT in blood donors as possible marker of liverinfectivity and hence increasing awareness among the people about the prevention and spread of HCV in Communityand to give suggestions in the formulation of blood transfusion policies. Setting: At Microbiology Department, BasicMedical Sciences Institute, Jinnah Postgraduate Medical Centre Karachi. Period: From September 2001 to January2002. Material and Methods: 150 subjects, consisting of volunteer blood donors and 50 subjects selected from healthypopulation who had never received or donated blood. Results: Among 150 blood donors, 07 subjects (4.66%) werefound to be anti HCV positive. Mean age of anti HCV positive donors was 32.85±7.35 years with male predominance.Conclusion: It is concluded that HCV is notorious for its infectivity, chronocity and complications. Hence HCV spreadshould be controlled by screening blood donors for anti HCV antibodies and observing Universal rules in medicalpractice.

Estilos ABNT, Harvard, Vancouver, APA, etc.

7

Dana, Franklin, Paul R. Becherer e Bruce R. Bacon. "Hepatitis C virus". Postgraduate Medicine 95, n.º 6 (junho de 1994): 121–30. http://dx.doi.org/10.1080/00325481.1994.11945847.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

8

Klevens, R. Monina, e Anne C. Moorman. "Hepatitis C virus". Journal of the American Dental Association 144, n.º 12 (dezembro de 2013): 1340–47. http://dx.doi.org/10.14219/jada.archive.2013.0069.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

9

Ye, Jin. "Hepatitis C Virus". Arteriosclerosis, Thrombosis, and Vascular Biology 32, n.º 5 (maio de 2012): 1099–103. http://dx.doi.org/10.1161/atvbaha.111.241448.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

10

Jadoul, Michel, Alberto Frosi, MariaClotilde Ragni, Leonardo Salvaggio, Silvia Vezzoli, Francesco Vezzoli, Medhat Darwish et al. "Hepatitis C virus". Lancet 345, n.º 8943 (janeiro de 1995): 189–91. http://dx.doi.org/10.1016/s0140-6736(95)90192-2.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

11

di Bisceglie, Adrian M. "Hepatitis C Virus". Gastroenterology 116, n.º 1 (janeiro de 1999): 224–25. http://dx.doi.org/10.1016/s0016-5085(99)70263-5.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

12

DONNELLY, K. "Hepatitis C virus". Journal of WOCN 26, n.º 3 (maio de 1999): 111–12. http://dx.doi.org/10.1016/s1071-5754(99)90026-8.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

13

Smith, C. I. "Hepatitis C Virus". BMJ 310, n.º 6974 (28 de janeiro de 1995): 268–69. http://dx.doi.org/10.1136/bmj.310.6974.268a.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

14

A-KADER, HASSAN HESHAM, e WILLIAM F. BALISTRERI. "Hepatitis C virus". Pediatric Infectious Disease Journal 12, n.º 10 (outubro de 1993): 853–67. http://dx.doi.org/10.1097/00006454-199310000-00011.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

15

Wright, Teresa L., e Brian J. G. Pereira. "Hepatitis C Virus". Seminars in Dialysis 10, n.º 5 (1 de outubro de 2007): 241–44. http://dx.doi.org/10.1111/j.1525-139x.1997.tb00502.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

16

Donnelly, Kevin. "Hepatitis C Virus". Journal of Wound, Ostomy and Continence Nursing 26, n.º 3 (maio de 1999): 111. http://dx.doi.org/10.1097/00152192-199905000-00005.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

17

Laique, Sobia N., e Hugo E. Vargas. "Hepatitis C Virus". American Journal of Gastroenterology 114, n.º 2 (fevereiro de 2019): 207–8. http://dx.doi.org/10.14309/ajg.0000000000000095.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

18

Farci, Patrizia. "HEPATITIS C VIRUS". Clinics in Liver Disease 5, n.º 4 (novembro de 2001): 895–916. http://dx.doi.org/10.1016/s1089-3261(05)70200-2.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

19

Pietschmann, Thomas, e Richard J. P. Brown. "Hepatitis C Virus". Trends in Microbiology 27, n.º 4 (abril de 2019): 379–80. http://dx.doi.org/10.1016/j.tim.2019.01.001.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

20

Keeffe, Emmet B. "Hepatitis C Virus". Clinics in Liver Disease 9, n.º 3 (agosto de 2005): xi—xiii. http://dx.doi.org/10.1016/j.cld.2005.05.001.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

21

&NA;. "Hepatitis C Virus". Pediatric Infectious Disease Journal 32 (novembro de 2013): L—1—L—14. http://dx.doi.org/10.1097/01.inf.0000437868.34196.30.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

22

Dultz, Georg, e Stefan Zeuzem. "Hepatitis C Virus". Gastroenterology Clinics of North America 44, n.º 4 (dezembro de 2015): 807–24. http://dx.doi.org/10.1016/j.gtc.2015.07.008.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

23

Ampuero, Javier, e Manuel Romero-Gómez. "Hepatitis C Virus". Gastroenterology Clinics of North America 44, n.º 4 (dezembro de 2015): 845–57. http://dx.doi.org/10.1016/j.gtc.2015.07.009.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

24

Asselah, Tarik, e Marc Bourlière. "Hepatitis C Virus". Gastroenterology Clinics of North America 44, n.º 4 (dezembro de 2015): 859–70. http://dx.doi.org/10.1016/j.gtc.2015.07.013.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

25

Falk, Gary W. "Hepatitis C Virus". Gastroenterology Clinics of North America 44, n.º 4 (dezembro de 2015): xiii. http://dx.doi.org/10.1016/j.gtc.2015.09.002.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

26

Roggendorf, M. "Hepatitis-C-Virus". DMW - Deutsche Medizinische Wochenschrift 115, n.º 09 (18 de agosto de 2009): 352–54. http://dx.doi.org/10.1055/s-0029-1235578.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

27

Ho, Monto. "Hepatitis C Virus". New England Journal of Medicine 325, n.º 7 (15 de agosto de 1991): 507–9. http://dx.doi.org/10.1056/nejm199108153250710.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

28

Pereira, C., C. A. Lee e G. Dusheiko. "Hepatitis C virus." BMJ 303, n.º 6805 (28 de setembro de 1991): 783. http://dx.doi.org/10.1136/bmj.303.6805.783.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

29

Tedder, R. S., e E. M. Briggs. "Hepatitis C virus". BMJ 303, n.º 6813 (23 de novembro de 1991): 1331. http://dx.doi.org/10.1136/bmj.303.6813.1331.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

30

Jarrett, Monica, e Paula Cox. "Hepatitis C virus". Nursing Clinics of North America 39, n.º 1 (março de 2004): 219–29. http://dx.doi.org/10.1016/j.cnur.2003.11.014.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

31

Sherlock, Sheila. "Hepatitis C virus". Digestive Diseases and Sciences 41, S12 (dezembro de 1996): 3S—5S. http://dx.doi.org/10.1007/bf02087871.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

32

Bréchot, Christian. "Hepatitis C virus". Digestive Diseases and Sciences 41, S12 (dezembro de 1996): 6S—21S. http://dx.doi.org/10.1007/bf02087872.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

33

Plagemann, P. G. W. "Hepatitis C virus". Archives of Virology 120, n.º 3-4 (setembro de 1991): 165–80. http://dx.doi.org/10.1007/bf01310473.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

34

Sajjad, Aiza, Shahnawaz Gardezi, Fatima Mukhtar, Amna Anjum, Qiarush Saeed e Noor Dawood. "HEPATITIS C VIRUS (HCV) INFECTION". Professional Medical Journal 22, n.º 11 (10 de novembro de 2015): 1403–8. http://dx.doi.org/10.29309/tpmj/2015.22.11.871.

Texto completo da fonte

Resumo:

Background: With a high magnitude of hepatitis C in the country and theburden still rising it was imperative to assess the knowledge of HCV infected individuals, whichwould determine the further spread of the disease or otherwise based on the adoption of goodpractices by these patients. Objectives: To evaluate the knowledge and practice regardingHCV in Hepatitis C patients presenting at Ghurki Trust Teaching Hospital, Lahore and toformulate recommendations based on study results to improve knowledge about hepatitisC. Study Design: Descriptive cross-sectional study. Setting: Ghurki Trust Teaching Hospital(GTTH), Lahore. Period: January to May 2015. Methods: The patients of hepatitis C registeredat GTTH for treatment were included in the study after obtaining voluntary informed consentfrom the respondents and approval of the study from the institutional ethical review board. Theconvenience non-probability sampling technique was used to recruit 169 study participants.A pre-tested structured questionnaire was used to collect information, which was recordedand analyzed using the statistical package for social sciences version 21.0. Data is describedin the form of frequencies and percentages for categorical variables and mean and standarddeviation for continuous variable. Results: Of the 169 HCV patients, 110(65%) had heard ofhepatitis C before acquiring it, the popular source of information regarding HCV was identifiedas relatives by 67(39.8%) of the patients. 70(41.4%) of the respondents were aware of a virusbeing the cause of hepatitis C, 140(82.8%) knew that HCV can be spread through sharinginjecting equipment, nearly half the respondents 87(51.5%) had asked their family membersto get tested for HCV and 68(40.2%) patients practiced safe sex. Conclusion: Majority of therespondents had heard of HCV before acquiring the disease. A large proportion of patients wereaware of the disease being spread through sharing injecting equipment. Half of the patients hadtheir family members tested for HCV. But less than half practiced safe sex.

Estilos ABNT, Harvard, Vancouver, APA, etc.

35

Yuki, Nobukazu, Norio Hayashi, Akinori Kasahara, Hideki Hagiwara, Hideyuki Fusamoto e Takenobu Kamada. "Antibodies to hepatitis C virus and hepatitis C virus infection". Gastroenterologia Japonica 28, S5 (maio de 1993): 76–79. http://dx.doi.org/10.1007/bf02989211.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

36

Mazzaro, C., G. Panarello, F. Tesio, G. Santini, M. Crovatto, G. Mazzi, F. Zorat et al. "Hepatitis C virus risk: a hepatitis C virus related syndrome". Journal of Internal Medicine 247, n.º 5 (maio de 2000): 535–45. http://dx.doi.org/10.1046/j.1365-2796.2000.00627.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

37

Andrade, Luís Jesuino, Paulo Melo, Isabel Lins, Raymundo Paraná e Augusto Lins. "HEPATITIS C VIRUS AND HEPATITIS C-INFECTION". Brazilian Journal of Medicine and Human Health 3, n.º 1 (31 de maio de 2015): 19–28. http://dx.doi.org/10.17267/2317-3386bjmhh.v3i1.453.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

38

Nouman, Muhammad Khuram, Bushra Zaidi, Ghulam Mohiuddin, Faryal Asif e Muhammad Khan Malik. "HEPATITIS C". Professional Medical Journal 25, n.º 03 (10 de março de 2018): 387–91. http://dx.doi.org/10.29309/tpmj/2018.25.03.381.

Texto completo da fonte

Resumo:

Background: Hepatitis C virus (HCV) is the most communal source of non-A,non-B viral hepatitis in the world. The disease is illusory, and the majority of patients do notacquire jaundice at its onset. Treatment of hepatitis C with interferon attained a sustainedvirological response (SVR) in almost 50% of the patients with HCV infection. Viral genotype isimportant to determine the response. The present study aims to provide the incidence of relapseof HCV in patients taking interferon therapy and to identify the predictors for relapse. StudyDesign: Retrospective observational study. Setting: Department of Medicine, DHQ TeachingHospital, Sargodha. Period: Two years. Methods: A total of 60 patients were retrospectivelyevaluated for this study. The exclusion criteria include the patients co- infected with hepatitisB virus or HIV. All the patients were monitored 2, 4, 8, 12, 16, and 24 weeks after the endof treatment with interferon alpha. Results: We observed that the patients with relapse weresignificantly older and heavier (P value < 0.05). At the start of treatment, viral load was higherin relapsed patients (P value < 0.04). Conclusion: On the bases of our study findings, we canconclude that low incidence of relapse occurred with interferon therapy. High ALT level, viralloads, older age and obesity were some of strong predictors of relapse among HCV patients.

Estilos ABNT, Harvard, Vancouver, APA, etc.

39

Calmet Schwartzmann, Fernando H., e Fernando H. Calmet Bruhn. "Hepatitis C". Diagnóstico 56, n.º 1 (13 de dezembro de 2018): 24–30. http://dx.doi.org/10.33734/diagnostico.v56i1.119.

Texto completo da fonte

Resumo:

El virus de la hepatitis C (VHC) es un virus monocatenario ARN perteneciente al género Hepacivirus de la familia Flaviviridae. En la década de 1970, tras el descubrimiento de hepatitis Ay B, se hizo claro que había casos de hepatitis post-transfusión que no podían ser explicados por estos virus, llevando a la descripción de hepatitis "no A, no B". No fue hasta 1989 que se aisló el VHC por primera vez y entre 1990 y 1992 se desarrolló y refinó una prueba de anticuerpos anti-VHC que fue implementado en los bancos de sangre, llevando a una gran reducción de la transmisión de este virus a nivel mundial. Desde entonces ha habido una proliferación de nuevos antivirales directos que han revolucionado el manejo de la hepatitis C, asociados a una eficacia que se aproxima a 100% y con efectos adversos mínimos.

Estilos ABNT, Harvard, Vancouver, APA, etc.

40

Calmet Schwartzmamn, Fernando H., e Fernando H. Calmet Bruhn. "Hepatitis C". Diagnóstico 56, n.º 1 (30 de janeiro de 2020): 24–30. http://dx.doi.org/10.33734/diagnostico.v56i1.166.

Texto completo da fonte

Resumo:

El virus de hepatitis C (VHC) es un virus monocatenario ARN perteneciente al género Hepacivirus de la familia Flaviviridae. En la década de 1970, tras el descubrimiento de hepatitis A y B, se hizo claro que había casos de hepatitis post-transfusión que no podían ser explicados por estos virus, llevando a la descripción de hepatitis ''no A, no B''. No fue hasta 1989 que se aisló el VHC por primera vez y emtre 1990 y 1992 se desarrolló y refinó una prueba de anticuerpos anti-VHC que fue implementado en los bancos de sangre, llevando a una gran reducción de la transmisión de este virus a nivel mundial. Desde entonces ha habido una proliferación de nuevos antivirales directos que han revolucionado el manejo de la hepatitis C, asociados a una eficacia que se aproxima a 100% y con efectos afversos mínimos.

Estilos ABNT, Harvard, Vancouver, APA, etc.

41

Belli, Luca S., Enrico Silini, Alberto Alberti, Giorgio Bellati, Claudio Vai, Ernesto Minola, Gianfranco Rondinara et al. "Hepatitis C virus genotypes, hepatitis, and hepatitis C virus recurrence after liver transplantation". Liver Transplantation and Surgery 2, n.º 3 (maio de 1996): 200–205. http://dx.doi.org/10.1002/lt.500020305.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

42

TANAKA, Yasuhito, e Masashi MIZOKAMI. "Genotype of hepatitis virus. 3. Hepatitis C virus." Kanzo 46, n.º 8 (2005): 480–85. http://dx.doi.org/10.2957/kanzo.46.480.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

43

Anjum, Muhammad Usman, Muhammad Safdar Khan, Nazar Muhamamd Afridi e Syed Humayun Shah. "HEPATITIS B AND C VIRUS INFECTIONS". Professional Medical Journal 22, n.º 10 (10 de outubro de 2015): 1284–88. http://dx.doi.org/10.29309/tpmj/2015.22.10.981.

Texto completo da fonte

Resumo:

Patients with end stage renal disease require haemodialysis as a part of theirtreatment. The incidence of hepatitis B and C virus infection is quite high in patients undergoingmaintenance haemodialysis than in general population. This risk is specifically associatedwith use of blood and its products as well as repeated intravascular access in these patients.Objectives: To determine the seropositivity of hepatitis B and C virus infection in patientsreceiving haemodialysis. Design: Descriptive cross sectional study. Setting: NephrologyDepartment, Ayub Teaching Hospital, Abbottabad, Pakistan. Period: From October 2014 toApril 2015. Methods: Five hundred patients were included in the study based on inclusionand exclusion criteria. Demographic data was recorded and detailed history was taken fromeach patient specifically about the no of blood transfusions received, the frequency of dialysisand the dialysis done in other centers. All patients were checked for the presence of hepatitisB surface antigen (HbsAg) and antibodies to HCV using third generation enzyme linkedimmunoassay (ELISA). Results: Mean age of study sample was 46±5 years with 60.8 % males.Incidence of hepatitis positive cases was 164 (32.8 %), out of which 66 (13.2 %) patients wereHBV positive and 98 (19.08 %) patients were HCV positive. The hepatitis B and C infectionswere more common in males than females. Seropositivity of HBV and HCV was higher (HBV18.1 % and HCV 22.2 %) among haemodialysis patients who have received more than threeblood transfusions. The frequency of HBV and HCV infections increases significantly with theincrease in frequency of dialysis, with 49 (17.11 %) patients were HBV positive and 70 (24.5%) patients were HCV positive cases, who have received haemodialysis for more than fivetimes. There were 48 (15.7 %) HBV positive cases as well as 68 (22.3 %) HCV positive cases inpatients who have received their treatment from a single center. Conclusion: Hepatitis B andC infection is quite common in patients undergoing haemodialysis. The risk of these infectionscan be reduced by following infection control guidelines, proper training of the staff and strictscreening of blood and blood products specifically for hepatitis C virus.

Estilos ABNT, Harvard, Vancouver, APA, etc.

44

Miyamura, Tathuo, Tethuro Suzuki e Yosiharu Mathuura. "Special issue: Hepatitis C virus. Structural proteins of hepatitis C virus." Uirusu 43, n.º 2 (1993): 275–83. http://dx.doi.org/10.2222/jsv.43.2_275.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

45

Soni, Dr Payal, Dr Dipa Kinariwala, Dr Neeta Khandelwal, Dr Mehul Patel, Dr P. K. Shah Dr. P. K. Shah e Dr M. M. Vegad Dr. M. M. Vegad. "Co-Infection of Hepatitis C Virus and Hepatitis B Virus in Human Immuno Deficiency Virus Positive Population in Ahmedabad, Gujarat." International Journal of Scientific Research 2, n.º 9 (1 de junho de 2012): 17–18. http://dx.doi.org/10.15373/22778179/sep2013/158.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

46

GUPTA, NEHA, SIMA K. BHATT e AMI M. SHAH. "Seroprevalence of Hepatitis-B Virus, Human Immunodeficiency Virus & Hepatitis-C Virus in Corneal Donors in Tertiary Care Centre, Ahmedabad". International Journal of Scientific Research 3, n.º 2 (1 de junho de 2012): 455–56. http://dx.doi.org/10.15373/22778179/feb2014/150.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

47

Ohkawa, Kazuyoshi, Norio Hayashi, Nobukazu Yuki, Hideki Hagiwara, Michio Kato, Keiji Yamamoto, Hiroshi Eguchi, Hideyuki Fusamoto, Manabu Masuzawa e Takenobu Kamada. "Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patients". Journal of Hepatology 21, n.º 4 (1994): 509–14. http://dx.doi.org/10.1016/s0168-8278(94)80094-4.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

48

Mosley, James W. "Hepatitis C Virus and Fulminant Hepatitis". Annals of Internal Medicine 115, n.º 12 (15 de dezembro de 1991): 983. http://dx.doi.org/10.7326/0003-4819-115-12-983_2.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

49

Bhamidimarri, Kalyan Ram, James Park e Douglas Dieterich. "Management of Hepatitis B Virus Coinfection: HIV, Hepatitis C Virus, Hepatitis D Virus". Current Hepatitis Reports 10, n.º 4 (4 de novembro de 2011): 262–68. http://dx.doi.org/10.1007/s11901-011-0115-1.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

50

Dubuisson, Jean. "Hepatitis C virus proteins". World Journal of Gastroenterology 13, n.º 17 (2007): 2406. http://dx.doi.org/10.3748/wjg.v13.i17.2406.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Oferecemos descontos em todos os planos premium para autores cujas obras estão incluídas em seleções literárias temáticas. Contate-nos para obter um código promocional único!